Analysis of Acquired EGFR T790M Mutation in Patients with Non-Small Cell Lung Cancer Who Received Icotinib Progress

被引:0
|
作者
Huang, R. [1 ]
Xu, C. [1 ]
Wang, W. [2 ]
Li, J. [3 ]
He, C. [1 ]
Zhu, Y. [4 ]
Zhuang, W. [1 ]
Huang, Z. [1 ]
Chen, Y. [5 ]
Chen, G. [1 ]
Fang, M. [2 ]
Lv, T. [6 ]
Song, Y. [7 ]
机构
[1] Fujian Canc Hosp, Fuzhou, Fujian, Peoples R China
[2] Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
[3] Nantong Tumor Hosp, Nantong, Peoples R China
[4] Zhejiang Rongjun Hosp, Jiaxing, Peoples R China
[5] Fujian Canc Hosp, Pathol, Fuzhou, Fujian, Peoples R China
[6] Jinling Hosp, Resp, Nanjing, Jiangsu, Peoples R China
[7] Nanjing Univ, Sch Med, Jinling Hosp, Dept Resp Med, Nanjing, Jiangsu, Peoples R China
关键词
L858R; 19del; T790M;
D O I
10.1016/j.jtho.2018.08.1599
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P3.01-39
引用
收藏
页码:S882 / S882
页数:1
相关论文
共 50 条
  • [1] Different characteristics and survival in non-small cell lung cancer patients with primary and acquired EGFR T790M mutation
    Wang, Shuyuan
    Yan, Bo
    Zhang, Yanwei
    Xu, Jianlin
    Qiao, Rong
    Dong, Yu
    Zhang, Bo
    Zhao, Yiming
    Zhang, Lele
    Qian, Jie
    Lu, Jun
    Zhao, Ruiying
    Han, Baohui
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (11) : 2880 - 2886
  • [2] Osimertinib for EGFR T790M mutation-positive non-small cell lung cancer
    Soejima, Kenzo
    Yasuda, Hiroyuki
    Hirano, Toshiyuki
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (01) : 31 - 38
  • [3] Plasma ctDNA Analysis for Detection of the EGFR T790M Mutation in Patients with Advanced Non-Small Cell Lung Cancer
    Jenkins, Suzanne
    Yang, James C-H.
    Ramalingam, Suresh S.
    Yu, Karen
    Patel, Sabina
    Weston, Susie
    Hodge, Rachel
    Cantarini, Mireille
    Janne, Pasi A.
    Mitsudomi, Tetsuya
    Goss, Glenwood D.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (07) : 1061 - 1070
  • [4] Afatinib increases sensitivity to radiation in non-small cell lung cancer cells with acquired EGFR T790M mutation
    Zhang, Shirong
    Zheng, Xiaoliang
    Huang, Haixiu
    Wu, Kan
    Wang, Bing
    Chen, Xufeng
    Ma, Shenglin
    [J]. ONCOTARGET, 2015, 6 (08) : 5832 - 5845
  • [5] Clinicopathological Characteristics of Non-small Cell Lung Cancer Patients With Primary Concomitant EGFR T790M Mutation
    Li, Hang
    Wang, Rui
    Hu, Haichuan
    Pan, Yunjian
    Wang, Lei
    Zhang, Yang
    Sun, Yihua
    Chen, Haiquan
    [J]. CHEST, 2014, 145 (03)
  • [6] Non-invasive and quantitative analysis for EGFR T790M mutation in the patients with advanced non-small cell lung cancer received EGFR-TKI therapy.
    Chen, Rui
    An, Tongtong
    Wang, Jie
    Bai, Hua
    Wang, Zhijie
    Zhao, Jun
    Wu, Meina
    Zhuo, Minglei
    Duan, Jianchun
    Wang, Yuyan
    Wang, Shuhang
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] Targeting the EGFR T790M mutation in non-small-cell lung cancer
    Normanno, Nicola
    Maiello, Monica Rosaria
    Chicchinelli, Nicoletta
    Iannaccone, Alessia
    Esposito, Claudia
    De Cecio, Rossella
    D'alessio, Amelia
    De Luca, Antonella
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2017, 21 (02) : 159 - 165
  • [8] Selection of Molecular Techniques for T790M EGFR Mutation Detection in Non-small Cell Lung Cancer
    Prim, Nathalie
    Quoix, Elisabeth
    Beau-Faller, Michele
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (09) : 1615 - 1616
  • [9] Plasma T790M Mutation Associates with Extensive Progression in Non-small Cell Lung Cancer with Acquired Resistance to EGFR Inhibitors
    Zhang, Shirong
    Zhu, Lucheng
    Xia, Bing
    Chen, Enguo
    Zhao, Qiong
    Chen, Xueqin
    Wang, Limin
    Jiang, Hong
    Chen, Xufeng
    Ma, Shenglin
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1251 - S1252
  • [10] Mixed Response of Non-Small Cell Lung Cancer Harboring the EGFR T790M Mutation to Osimertinib
    Shinno, Y.
    Goto, Y.
    Sato, J.
    Morita, R.
    Matsumoto, Y.
    Murakami, S.
    Kanda, S.
    Horinouchi, H.
    Fujiwara, Y.
    Yamamoto, N.
    Ohe, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2145 - S2145